|
|
||||||||






* Curriculum in Genetics and Molecular Biology and
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599;
H. Lee Moffitt Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, University of Southern Florida, Tampa, FL 33612;
Department of Pediatrics and Center for Environmental Medicine and Lung Biology, University of North Carolina, Chapel Hill, NC 27599; and
¶ Department of Basic Sciences, Mercer University School of Medicine, Macon, GA 31207
Although activated human T cells express MHC class II antigens, the regulation of these antigens in T cells is poorly understood. This study focuses on the control of the MHC2TA gene in these cells. MHC2TA encodes the transcriptional master regulator of MHC class II, the class II trans-activator (CIITA). It has at least three distinct promoters (PI, PIII, and PIV), each active in an overlapping subset of cell types and directing a slightly different product. This report used highly purified blood T cells prepared by negative immunoselection to analyze CIITA. Real-time PCR analysis indicates that resting T cells do not express detectable CIITA transcript, while activated T cells express the PIII CIITA form. Transient transfection of activated blood T cells using wild-type and mutant PIII promoter-reporter constructs shows that two promoter elements, activation response element-1 (ARE-1) and ARE-2, are important for PIII function. cAMP response element binding protein, a known activator of gene expression in activated T cells, activates PIII in primary T cells. However, an intact ARE-2 site is not required for this activation, indicating that cAMP response element binding protein does not activate via this site. EMSAs indicate that an activating transcription factor/cAMP response element binding protein/cAMP response element modulator family member, but not phosphorylated cAMP response element binding protein-1, binds to ARE-2. ARE-2 also forms a complex with an unidentified protein. The ARE-2 binding protein is constitutively expressed in a DR+ T cell line, reflecting differences between the DR+ cell line and primary blood lymphocytes. These results show that MHC2TA PIII is induced in activated T lymphocytes, and that the induced binding of ARE-2 is a crucial step in this process.
This article has been cited by other articles:
![]() |
J. Wang, G. Roderiquez, T. Jones, P. McPhie, and M. A. Norcross Control of In Vitro Immune Responses by Regulatory Oligodeoxynucleotides through Inhibition of pIII Promoter Directed Expression of MHC Class II Transactivator in Human Primary Monocytes J. Immunol., July 1, 2007; 179(1): 45 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Green, H. Yoon, and J. M. Boss Epigenetic Regulation during B Cell Differentiation Controls CIITA Promoter Accessibility J. Immunol., September 15, 2006; 177(6): 3865 - 3873. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zika, L. Fauquier, L. Vandel, and J. P.-Y. Ting Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-{gamma}-inducible MHC-II gene expression PNAS, November 8, 2005; 102(45): 16321 - 16326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Lee, K. Howcroft, A. Kotekar, H. H. Yang, K. H. Buetow, and D. S. Singer ATG deserts define a novel core promoter subclass Genome Res., September 1, 2005; 15(9): 1189 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Wang, S. Gregoire, E. Zika, L. Xiao, C. S. Li, H. Li, K. L. Wright, J. P. Ting, and X.-J. Yang Identification of the Ankyrin Repeat Proteins ANKRA and RFXANK as Novel Partners of Class IIa Histone Deacetylases J. Biol. Chem., August 12, 2005; 280(32): 29117 - 29127. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Howcroft, J. D. Weissman, A. Gegonne, and D. S. Singer A T Lymphocyte-Specific Transcription Complex Containing RUNX1 Activates MHC Class I Expression J. Immunol., February 15, 2005; 174(4): 2106 - 2115. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. van der Stoep, E. Quinten, M. M. Rezende, and P. J. van den Elsen E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII) Blood, November 1, 2004; 104(9): 2849 - 2857. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Park, Y. Bae, D. H. Chung, Y.-L. Choi, B. K. Kim, Y. C. Sung, E. Y. Choi, S. H. Park, and K. C. Jung T cell expression of CIITA represses Th1 immunity Int. Immunol., October 1, 2004; 16(10): 1355 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Holling, E. Schooten, A. W. Langerak, and P. J. van den Elsen Regulation of MHC class II expression in human T-cell malignancies Blood, February 15, 2004; 103(4): 1438 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. O'Connor Jr, J. A. Harton, X. Zhu, M. W. Linhoff, and J. P.-Y. Ting Cutting Edge: CIAS1/Cryopyrin/PYPAF1/NALP3/ CATERPILLER 1.1 Is an Inducible Inflammatory Mediator with NF-{kappa}B Suppressive Properties J. Immunol., December 15, 2003; 171(12): 6329 - 6333. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. C. Hornell, G. W. Beresford, A. Bushey, J. M. Boss, and E. D. Mellins Regulation of the Class II MHC Pathway in Primary Human Monocytes by Granulocyte-Macrophage Colony-Stimulating Factor J. Immunol., September 1, 2003; 171(5): 2374 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zika, S. F. Greer, X.-S. Zhu, and J. P.-Y. Ting Histone Deacetylase 1/mSin3A Disrupts Gamma Interferon-Induced CIITA Function and Major Histocompatibility Complex Class II Enhanceosome Formation Mol. Cell. Biol., May 1, 2003; 23(9): 3091 - 3102. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Otten, F. Tacchini-Cottier, M. Lohoff, F. Annunziato, L. Cosmi, L. Scarpellino, J. Louis, V. Steimle, W. Reith, and H. Acha-Orbea Deregulated MHC Class II Transactivator Expression Leads to a Strong Th2 Bias in CD4+ T Lymphocytes J. Immunol., February 1, 2003; 170(3): 1150 - 1157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |